A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke

Completed

Phase 2 Results

Update History

23 Jan '13
A location was updated in Birmingham.
New
The overall status was removed for University of Alabama at Birmingham.
A location was updated in La Jolla.
New
The overall status was removed for University of California, San Diego.
A location was updated in Newport Beach.
New
The overall status was removed for Hoag Memorial Hospital Presbyterian.
A location was updated in Fairfield.
New
The overall status was removed for Associated Neurologists of Southern CT, PC.
A location was updated in Atlantis.
New
The overall status was removed for JEM Research Institute.
A location was updated in Fort Lauderdale.
New
The overall status was removed for Neurologic Consultants, PA.
A location was updated in Decatur.
New
The overall status was removed for NeuroStudies.net.
A location was updated in Lexington.
New
The overall status was removed for Associates in Neurology, PSC.
A location was updated in Boston.
New
The overall status was removed for Boston Medical Center.
A location was updated in Great Falls.
New
The overall status was removed for Advanced Neurology Specialists.
A location was updated in Reno.
New
The overall status was removed for Renown Neuroscience Institute.
A location was updated in New Brunswick.
New
The overall status was removed for UMDNJ -Robert Wood Johnson Medical School.
A location was updated in Buffalo.
New
The overall status was removed for Mercy Hospital of Buffalo.
A location was updated in West Haverstraw.
New
The overall status was removed for Helen Hayes Hospital.
A location was updated in White Plains.
New
The overall status was removed for The Burke Rehabilitation Hospital.
A location was updated in Charlotte.
New
The overall status was removed for Neuroscience & Spine Institute.
A location was updated in Philadelphia.
New
The overall status was removed for University of Pennsylvania.
A location was updated in Norfolk.
New
The overall status was removed for Sentara Medical Group/Sentara Neurology Specialists.
12 Sep '12
Trial name was updated.
New
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Trial was updated to "Phase 2."